Market research
ZU1.F Suzuken Co., Ltd
F EUR Not available
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 2B
- P/E ratio
- 31.81
- Analyst target
- Not available
- Dividend yield
- 2.1%
- Beta
- 0.09
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Not available
- Industry
- Not available
- ISIN
- Not available
- Market cap
- 2B
- P/E ratio
- 31.81
- Analyst target
- Not available
- Dividend yield
- 2.1%
- Beta
- 0.09
About
About Suzuken Co., Ltd
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business. The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions. The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the ZU1.F discussion.
5 years, 5 months ago
Suzuken Co., Ltd is currently in a long term downtrend where the price is trading 15.9% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.2.
Suzuken Co., Ltd's total revenue sank by 1.3% to $565B since the same quarter in the previous year.
Its net income has dropped by 75.7% to $2B since the same quarter in the previous year.
Based on the above factors, Suzuken Co., Ltd gets an overall score of 1/5.